- Home
- Member Resources
- Articles
- Precision Medicine
-
Genomic profiling helps to accurately classify disease, provide prognostic risk classification, and drive therapy management for patients with chronic myeloid stem cell disorders and acute leukemia.
-
Exciting clinical microbiology advancements have been made in the last several years, especially regarding the rapid molecular identification of pathogenic organisms and workflow automation.
-
Molecular diagnostics have broadened our ability to diagnose and identify prognostic markers in cases of myeloproliferative neoplasms. However, challenges remain, specifically with so-called “triple-negative” MPNs.
-
This article summarizes the utility of next-generation sequencing (NGS) for human leukocyte antigen genotyping, highlighting the advantages of this approach over other molecular methods for typing HLA alleles.
-
This article by CAP member Dr. Jordan Laser focuses on the role of the pathologist in utilization management.
-
This article focuses on germline genetic variants that can be used to identify the most appropriate medication and dose for a patient.